← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Director Jason P Rhodes sold $256K of Replimune Group, Inc.

Sold$256,446
$46.14Price
5,558Shares

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, Jan 26. Filed Thu, Jan 28, 5:08 PM ET, after the close. Not investment advice.